Altamira Therapeutics Market Cap

Altamira Therapeutics has a market cap or net worth of $286.35 thousand as of March 16, 2026. Its market cap has decreased by -82.83% in one year.

Market Cap

286.35K

Enterprise Value

1.07M

Revenue

n/a

Ranking

n/a

PE Ratio

n/a

Stock Price

$0.05

Market Cap Chart

Since August 8, 2014, Altamira Therapeutics's market cap has decreased from 171.70M to 286.35K, a decrease of -99.83%. That is a compound annual growth rate of -42.36%.

Market Cap History

Date	Market Cap	% Change
Mar 16, 2026	286.35K	-45.83%
Dec 31, 2025	528.62K	40.64%
Dec 31, 2024	375.87K	-72.84%
Dec 29, 2023	1.38M	-75.59%
Dec 30, 2022	5.67M	-78.93%
Dec 31, 2021	26.91M	-10.02%
Dec 31, 2020	Upgrade Pro	Upgrade Pro
Dec 31, 2019	Upgrade Pro	Upgrade Pro
Dec 31, 2018	Upgrade Pro	Upgrade Pro
Dec 29, 2017	Upgrade Pro	Upgrade Pro
Dec 30, 2016	Upgrade Pro	Upgrade Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
Scorpius Holdings	733.71K
Hepion Pharmaceuticals	720.46K
SQZ Biotechnologies Company	707.79K
Bio-Path Holdings	610.74K
Aibotics	458.46K
Windtree Therapeutics	432.78K
Oncology Pharma	425.30K
Regenerative Medical Technology Group	394.17K

Market Cap Rankings